Thrombolysis for acute stroke in routine clinical practice

Archives of Internal Medicine

Volumn 162, Issue 17, 2002, Pages 1994-2001

  Bravata, Dawn M ^a   Kim, Nancy ^a   Concato, John ^a   Krumholz, Harlan M ^a   Brass, Lawrence M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STROKE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOLS; COHORT STUDIES; CONNECTICUT; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0037163461     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.17.1994     Document Type: Article

References (29)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Kwiatkowski TG, Libman RB, Frankel M, et al, for the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med. 1999;340:1781-1787.
3. Fagan SC, Morgenstern LB, Petitta A, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke: NINDS rt-PA Stroke Study Group. Neurology. 1998;50:883-890.
4. Adams HP Jr, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation. 1996;94:1167-1174.
5. Zweifier RM, Brody ML, Graves GC, et al. Intravenous t-PA for acute ischemic stroke: therapeutic yield of a stroke code system. Neurology. 1998;50:501-503.
6. Hademenos G. Metro Stroke Task Force: first-year experience. Stroke. 1999;30: 2512.
7. Tanne D, Bates VE, Verro P, et al, and the t-PA Stroke Survey Group. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. Neurology. 1999;53:424-427.
8. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissuetype plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA. 2000;283:1145-1150.
9. Hanson SK, Brauer DJ, Anderson DC, et al. Stroke treatment in the community (STIC): intravenous rt-PA therapy for acute stroke in clinical practice [abstract]. Neurology. 1998;50(suppl 4):A155-A156.
10. Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke. 2001;32:1832-1840.
11. Hacke W, Brott T, Caplan L, et al. Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology. 1999;53(suppl 4):S3-S14.
12. Buchan AM, Barber PA, Newcommon N, et al. Effectiveness of t-PA on acute ischemic stroke: outcome relates to appropriateness. Neurology. 2000;54:679-684.
13. Tanne D, Gorman MJ, Bates VE, et al. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: the tPA stroke survey experience. Stroke. 2000;31:370-375.
14. Viilar-Cordova C, Morgenstern LB, Barnholtz JS, Frankowski RF, Grotta JC. Neurologists' attitudes regarding rt-PA for acute ischemic stroke. Neurology. 1998; 50:1491-1494.
15. Meschia JF, Williams LS, Fleck JD, Bruno A, Biller J. Views of the use of tissue plasminogen activator in acute ischemic stroke: a statewide survey among neurologists and emergency medicine physicians in Indiana. J Stroke Cerebrovasc Dis. 1999;8:207-210.
16. Lopez-Yunez AM, Bruno A, Williams LS, Yilmaz E, Zurru C, Billet J. Protocol violations in community-based rTPA stroke treatment are associated with symptomatic intracerebral hemorrhage. Stroke. 2001;32:12-16.
17. Katzan IL, Furlan AJ, Lloyd LE, et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA. 2000;283: 1151-1158.
18. Bath P. Alteplase not yet proven for acute ischaemic stroke. Lancet. 1998;352: 1238-1239.
19. Williams LS, Yilmaz EY, Lopez-Yunez AM. Retrospective assessment of initial stroke severity with the NIH Stroke Scale. Stroke. 2000;31:858-862.
20. Kasner SE, Chalela JA, Luciano JM, et al. Reliability and validity of estimating the NIH stroke scale score from medical records. Stroke. 1999;30:1534-1537.
21. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial. Stroke. 1997;28:2119-2125.
22. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997;28:2109-2118.
23. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke: potential contributing factors in the European Cooperative Acute Stroke Study. Stroke. 1997;28:957-960.
24. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
25. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? a framework for improvement. JAMA. 1999;282:1458-1465.
26. Benesch C, Witter DM Jr, Wilder AL, Duncan PW, Samsa GP, Matchar DB. Inaccuracy of the International Classification of Diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease. Neurology. 1997;49: 660-664.
27. Luck J, Peabody JW, Dresselhaus TR, Lee M, Glassman P. How well does chart abstraction measure quality? a prospective comparision of standardized patients with the medical record. Am J Med. 2000;108:642-649.
28. Alberts MA, Hademenos G, Latchaw RE, et al, for the Brain Attack Coalition. Recommendations for the establishment of primary stroke centers. JAMA. 2000; 283:3102-3109.
29. Zalenski RJ, Selker HP, Cannon CP, et al. National Heart Attack Alert Program position paper: chest pain centers and programs for the evaluation of acute cardiac ischemia. Ann Emerg Med. 2000;35:462-471.